Martine Zimmermann

Business address
C/O Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard Suite 110, San Diego, CA, 92121
Top holdings (ownership)
LGND
Get insider transactions for this reporting owner
Martine Zimmermann has filed 5 SEC EDGAR filings since 25 Sep 2023

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 24 Sep 2025 22 Sep 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 10 Jun 2025 06 Jun 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 18 Jun 2024 14 Jun 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 26 Sep 2023 22 Sep 2023 001-33093
3 Open Document Open Filing PRIMARY DOCUMENT 25 Sep 2023 22 Sep 2023 001-33093